VYNE THERAPEUTICS INC (VYNE)
US92941V3087 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to VYNE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.69. This target is 121.59% above the current price.
VYNE was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about VYNE.
In the previous month the buy percentage consensus was at a similar level.
VYNE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | Cantor Fitzgerald | Maintains | Overweight |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-19 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-14 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-07 | HC Wainwright & Co. | Maintains | Buy |